RNXT Stock Analysis: Buy, Sell, or Hold?

RNXT - RenovoRx, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.92
-0.04 (-3.67%) ▼
5d: -1.06%
30d: +1.05%
90d: -5.14%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026

Get Alerted When RNXT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: RNXT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: RNXT is currently trading at $0.92, which is considered fair relative to its 30-day fair value range of $0.88 to $0.95.

Technical Outlook: Technically, RNXT is in a downtrend. Immediate support is located at $0.85, while resistance sits at $0.99. Short-term momentum is weak, with the stock down 3.7% recently.

Market Sentiment: RNXT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.03 (+664.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.88 - $0.95
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 81.6%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.7%)
  • BULLISH: Trading 664.0% below Wall St target ($7.03)

Trading Range Analysis

30-Day Trading Range $0.88 - $0.95
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.85
Resistance Level $0.99
Current Trend Downtrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -6.13
Wall Street Target $7.03 (+664.0%)
Revenue Growth (YoY) 185.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ramtin Agah BUY 10000 shares 2026-01-21

Unlock Insider Activity

See real-time buying/selling by company executives for RNXT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 59 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 54 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$93 63 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$9 62 BUY

More Analysis for RNXT

RNXT Technical Chart RNXT Price Prediction RNXT Earnings Date RNXT Investment Advisor RNXT Fair Price Analyzer RNXT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals